- Home
- LRMR vs NUW Comparison
LRMR vs NUW Comparison
Compare LRMR & NUW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LRMR | NUW |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.1M | 256.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LRMR | NUW |
|---|---|---|
| Price | $3.72 | $14.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $16.71 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 45.3K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.66% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.61 | $12.45 |
| 52 Week High | $5.37 | $14.44 |
Technical Indicators
Market Signals| Indicator | LRMR | NUW |
|---|---|---|
| Relative Strength Index (RSI) | 56.32 | 61.11 |
| Support Level | $3.05 | $14.23 |
| Resistance Level | $3.72 | $14.55 |
| Average True Range (ATR) | 0.23 | 0.11 |
| MACD | 0.05 | -0.00 |
| Stochastic Oscillator | 94.37 | 79.43 |
Price Performance
Historical ComparisonAbout LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About NUW Nuveen AMT-Free Municipal Value Fund
Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations. The fund predominantly invests in long-term municipal bonds, corporate bonds, short-term municipal bonds, and other assets.